Shefali Patel

561 total citations
22 papers, 219 citations indexed

About

Shefali Patel is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Shefali Patel has authored 22 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Shefali Patel's work include Biosimilars and Bioanalytical Methods (7 papers), Inflammatory mediators and NSAID effects (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Shefali Patel is often cited by papers focused on Biosimilars and Bioanalytical Methods (7 papers), Inflammatory mediators and NSAID effects (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Shefali Patel collaborates with scholars based in United States, India and United Kingdom. Shefali Patel's co-authors include Ray Bakhtiar, Katie F. Maass, Matthew Barfield, Philip Timmerman, Christopher James, Enaksha Wickremsinhe, Neil Spooner, Melanie Anderson, Pooja Agarwal and Steve W. C. Chang and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Shefali Patel

17 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shefali Patel United States 9 73 52 35 34 25 22 219
Stefan Gaugler Switzerland 13 156 2.1× 83 1.6× 33 0.9× 44 1.3× 25 335
Melanie Anderson United States 12 145 2.0× 72 1.4× 23 0.7× 57 1.7× 20 282
Stacy Ho United States 6 51 0.7× 50 1.0× 21 0.6× 23 0.7× 10 155
Mark Yancey United States 10 39 0.5× 96 1.8× 26 0.7× 10 0.3× 13 330
Nico van de Merbel United Kingdom 5 159 2.2× 61 1.2× 18 0.5× 66 1.9× 12 251
Lisa Delahaye Belgium 8 213 2.9× 55 1.1× 16 0.5× 75 2.2× 13 332
Yun Lan Yueh United States 8 106 1.5× 62 1.2× 12 0.3× 33 1.0× 10 384
S. Jeal United Kingdom 9 44 0.6× 46 0.9× 51 1.5× 20 0.6× 10 361
Nele Sadones Belgium 7 229 3.1× 74 1.4× 24 0.7× 61 1.8× 8 394

Countries citing papers authored by Shefali Patel

Since Specialization
Citations

This map shows the geographic impact of Shefali Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shefali Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shefali Patel more than expected).

Fields of papers citing papers by Shefali Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shefali Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shefali Patel. The network helps show where Shefali Patel may publish in the future.

Co-authorship network of co-authors of Shefali Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Shefali Patel. A scholar is included among the top collaborators of Shefali Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shefali Patel. Shefali Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Shefali, et al.. (2024). Case Studies on the use of Microsampling for Nonclinical Studies in Pharmaceutical Drug Discovery and Development. The AAPS Journal. 26(6). 110–110. 1 indexed citations
2.
Patel, Shefali, et al.. (2024). High Sensitivity Circulating Tumor-DNA Assays in Renal Cell Carcinoma–Are we there yet?. Clinical Genitourinary Cancer. 22(6). 102235–102235.
3.
Patel, Shefali, et al.. (2024). Association of Copper, Zinc, Copper-to-zinc ratio and Disease Severity Scores in Sickle Cell Anemia: An Observational Analytical Study. Journal of the Association of Physicians of India. 72(12). e12–e16. 1 indexed citations
4.
Snyder, Linda A., Rajendra N. Damle, Shefali Patel, et al.. (2022). Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors. Molecular Cancer Therapeutics. 21(7). 1115–1124. 4 indexed citations
6.
7.
Maass, Katie F., Matthew Barfield, Christopher James, et al.. (2022). Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality. Clinical and Translational Science. 15(12). 2785–2795. 28 indexed citations
8.
Agarwal, Pooja, et al.. (2021). Clinical Features of Mycetoma and the Appropriate Treatment Options. SHILAP Revista de lepidopterología. Volume 12. 173–179. 31 indexed citations
9.
James, Christopher, Matthew Barfield, Katie F. Maass, Shefali Patel, & Melanie Anderson. (2020). Will patient-centric sampling become the norm for clinical trials after COVID-19?. Nature Medicine. 26(12). 1810–1810. 27 indexed citations
10.
Shi, Yifan, Heather E. Murrey, Kay Ahn, Naidong Weng, & Shefali Patel. (2020). LC-MS/MS assay for the simultaneous quantitation of thromboxane B2 and prostaglandin E2 to evaluate cyclooxygenase inhibition in human whole blood. SHILAP Revista de lepidopterología. 6(3). 131–144.
11.
Smith, Melissa, Diana Chin, Szeman Ruby Chan, et al.. (2020). Abstract 5567: In vivo administration of the STING agonist, JNJ-67544412, leads to complete regression of established murine subcutaneous tumors. Cancer Research. 80(16_Supplement). 5567–5567. 9 indexed citations
12.
Patel, Shefali, et al.. (2019). Microsampling for Quantitative Bioanalysis, an Industry Update: Output from an AAPS/EBF Survey. Bioanalysis. 11(7). 619–628. 34 indexed citations
13.
Patel, Shefali. (2019). Bioanalytical challenges and strategies for accurately measuring acyl glucuronide metabolites in biological fluids. Biomedical Chromatography. 34(1). e4640–e4640. 9 indexed citations
14.
Patel, Shefali. (2019). Perspectives on Gender Parity in Bioanalysis: An Interview with Shefali Patel. Bioanalysis. 11(7). 667–669.
15.
Shi, Yifan, Matthew M. Rankin, Lisa Norquay, Naidong Weng, & Shefali Patel. (2018). Bioanalysis of sulprostone, a prostaglandin E2 analogue and selective EP3 agonist, in monkey plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 1092. 51–57. 3 indexed citations
16.
Rankin, Matthew M., Lili Guo, Shuyuan Zhao, et al.. (2018). Therapeutic Potential of EP3 Receptor Antagonists for Treatment of Noninsulin Dependent Diabetes Mellitus across Multiple Preclinical Models. Diabetes. 67(Supplement_1). 2 indexed citations
17.
Patel, Shefali, et al.. (2016). A Review on Significances of Impurity Profiling. Research Journal of Pharmaceutical Dosage Forms and Technology. 8(1). 31–31. 7 indexed citations
18.
Denniff, Philip, et al.. (2014). Bioanalysis Zone: DBS Survey Results. Bioanalysis. 6(3). 287–291. 10 indexed citations
19.
Xia, Yuanqing, Steve W. C. Chang, Shefali Patel, et al.. (2004). Trace level quantification of deuterated 17β‐estradiol and estrone in ovariectomized mouse plasma and brain using liquid chromatography/tandem mass spectrometry following dansylation reaction. Rapid Communications in Mass Spectrometry. 18(14). 1621–1628. 30 indexed citations
20.
Raymond, Daniel P., Traves D. Crabtree, Shawn J. Pelletier, et al.. (2000). Extremes of White Blood Cell Count do not Independently Predict Outcome among Surgical Patients with Infection. The American Surgeon. 66(12). 1124–1131. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026